tiprankstipranks
Trending News
More News >
MustGrow Biologics (MGROF)
OTHER OTC:MGROF
US Market

MustGrow Biologics (MGROF) Ratios

Compare
12 Followers

MustGrow Biologics Ratios

MGROF's free cash flow for Q3 2025 was C$0.21. For the 2025 fiscal year, MGROF's free cash flow was decreased by C$ and operating cash flow was C$-3.07. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.89 1.61 5.72 4.63 11.24
Quick Ratio
1.25 1.12 5.72 4.63 11.24
Cash Ratio
1.09 1.03 5.62 4.56 11.15
Solvency Ratio
-2.02 -1.58 -0.50 -2.94 -2.46
Operating Cash Flow Ratio
-1.59 -1.24 -0.24 -2.11 -2.79
Short-Term Operating Cash Flow Coverage
-11.40 -9.09 -0.48 -8.06 -6.57
Net Current Asset Value
C$ 2.52MC$ 1.41MC$ 5.58MC$ 5.24MC$ 8.46M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.10 0.11 0.11 0.08
Debt-to-Equity Ratio
0.20 0.24 0.14 0.14 0.09
Debt-to-Capital Ratio
0.17 0.19 0.12 0.13 0.08
Long-Term Debt-to-Capital Ratio
0.04 0.05 0.02 0.06 0.04
Financial Leverage Ratio
2.08 2.50 1.24 1.36 1.15
Debt Service Coverage Ratio
-9.42 -13.00 -1.09 -13.41 -7.17
Interest Coverage Ratio
-24.81 0.00 0.00 -551.93 -57.07
Debt to Market Cap
0.02 <0.01 0.01 <0.01 <0.01
Interest Debt Per Share
0.02 0.01 0.02 0.02 0.02
Net Debt to EBITDA
0.43 0.48 8.95 1.13 2.95
Profitability Margins
Gross Profit Margin
17.62%75.56%91.84%100.00%100.00%
EBIT Margin
-83.13%-1228.27%-14.37%-85750.50%-23398.17%
EBITDA Margin
-83.02%-1284.91%-14.37%-85750.50%-23398.17%
Operating Profit Margin
-81.08%-1284.91%-17.08%-85750.50%-23398.17%
Pretax Profit Margin
-84.52%-1228.27%-14.37%-85905.87%-23808.18%
Net Profit Margin
-84.52%-1228.27%-14.37%-85905.87%-23808.18%
Continuous Operations Profit Margin
-84.52%-1228.27%-14.37%-85905.87%-23808.18%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
104.24%95.59%84.09%100.18%101.75%
Return on Assets (ROA)
-105.13%-90.26%-9.76%-78.01%-31.58%
Return on Equity (ROE)
-459.98%-225.33%-12.12%-106.24%-36.23%
Return on Capital Employed (ROCE)
-199.74%-202.97%-14.06%-99.31%-34.07%
Return on Invested Capital (ROIC)
-175.01%-175.56%-12.69%-92.62%-32.71%
Return on Tangible Assets
-108.49%-100.99%-9.76%-78.01%-31.58%
Earnings Yield
-20.08%-8.24%-1.05%-3.21%-1.97%
Efficiency Ratios
Receivables Turnover
41.22 3.87 49.70 0.07 0.20
Payables Turnover
2.42 0.04 1.20 0.00 0.00
Inventory Turnover
3.20 0.07 0.00 0.00 0.00
Fixed Asset Turnover
37.92 2.21 0.00 0.00 0.00
Asset Turnover
1.24 0.07 0.68 <0.01 <0.01
Working Capital Turnover Ratio
3.44 0.11 0.83 <0.01 <0.01
Cash Conversion Cycle
-28.16 -3.93K -297.94 4.95K 1.82K
Days of Sales Outstanding
8.85 94.25 7.34 4.95K 1.82K
Days of Inventory Outstanding
113.91 5.37K 0.00 0.00 0.00
Days of Payables Outstanding
150.92 9.39K 305.29 0.00 0.00
Operating Cycle
122.76 5.46K 7.34 4.95K 1.82K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.09 -0.07 >-0.01 -0.07 -0.06
Free Cash Flow Per Share
-0.09 -0.07 >-0.01 -0.07 -0.06
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-220.32 -894.57K -73.69K 0.00 0.00
Capital Expenditure Coverage Ratio
-220.32 -894.57K -73.69K 0.00 0.00
Operating Cash Flow Coverage Ratio
-8.16 -6.91 -0.39 -4.29 -3.22
Operating Cash Flow to Sales Ratio
-0.63 -8.99 -0.06 -502.78 -187.41
Free Cash Flow Yield
-14.02%-6.03%-0.46%-1.88%-1.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.98 -12.14 -95.08 -31.17 -50.82
Price-to-Sales (P/S) Ratio
4.53 149.08 13.66 26.78K 12.10K
Price-to-Book (P/B) Ratio
10.91 27.35 11.53 33.12 18.41
Price-to-Free Cash Flow (P/FCF) Ratio
-7.13 -16.58 -218.36 -53.26 -64.56
Price-to-Operating Cash Flow Ratio
-6.66 -16.58 -218.36 -53.26 -64.56
Price-to-Earnings Growth (PEG) Ratio
0.55 -0.02 1.08 -0.55 2.30
Price-to-Fair Value
10.91 27.35 11.53 33.12 18.41
Enterprise Value Multiple
-5.02 -11.12 -86.13 -30.10 -48.76
Enterprise Value
31.44M 56.86M 58.31M 167.24M 146.83M
EV to EBITDA
-5.02 -11.12 -86.13 -30.10 -48.76
EV to Sales
4.17 142.85 12.37 25.81K 11.41K
EV to Free Cash Flow
-6.57 -15.89 -197.81 -51.34 -60.88
EV to Operating Cash Flow
-6.60 -15.89 -197.81 -51.34 -60.88
Tangible Book Value Per Share
0.05 0.03 0.11 0.11 0.19
Shareholders’ Equity Per Share
0.05 0.04 0.11 0.11 0.19
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
0.14 <0.01 0.09 <0.01 <0.01
Net Income Per Share
-0.12 -0.09 -0.01 -0.11 -0.07
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.02 1.00 1.00 1.00 1.02
Research & Development to Revenue
0.08 1.94 0.18 73.45 35.62
SG&A to Revenue
0.49 8.41 0.66 697.47 155.23
Stock-Based Compensation to Revenue
0.18 3.70 0.29 261.54 21.04
Income Quality
0.75 0.73 0.44 0.59 0.79
Currency in CAD